Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.422E-14 | 3.097E-10 | CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 1.072E-09 | 3.336E-06 | CYP1A2, CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 1.072E-09 | 3.336E-06 | CYP1A2, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 5.981E-09 | 9.302E-06 | CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4, PTGS1 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 2.028E-08 | 2.103E-05 | AKR1B1, AKR1B10, CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 2.284E-07 | 1.777E-04 | CYP1A2, CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 2.508E-06 | 1.517E-03 | CYP1A2, CYP2C19, CYP2C9 |
BP | GO:0065007; biological regulation | GO:0006919; activation of cysteine-type endopeptidase activity involved in apoptotic process | 3.565E-06 | 1.991E-03 | CASP1, CASP7, MAPT, XDH |
BP | GO:0051179; localization | GO:1904823; purine nucleobase transmembrane transport | 4.821E-06 | 2.363E-03 | SLC28A1, SLC28A3 |
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 4.821E-06 | 2.363E-03 | CYP2D6, CYP3A4 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00040 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 9.207E-04 | 3.617E-03 | AKR1B10; AKR1B1 |
hsa00051 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 7.271E-04 | 3.076E-03 | AKR1B10; AKR1B1 |
hsa00052 | Galactose metabolism_Homo sapiens_hsa00052 | 6.387E-04 | 2.927E-03 | AKR1B10; AKR1B1 |
hsa00140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.376E-03 | 7.508E-03 | CYP1A2; CYP3A4 |
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.497E-05 | 9.146E-05 | CYP1A2; XDH |
hsa00240 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 7.570E-03 | 2.082E-02 | CDA; TK1 |
hsa00561 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.457E-03 | 7.508E-03 | AKR1B10; AKR1B1 |
hsa00590 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.008E-06 | 9.244E-06 | CYP2C9; ALOX15; CYP2C19; PTGS1 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.320E-10 | 1.276E-08 | CYP2C9; CYP1A2; ALOX15; CYP3A4; CYP2C19 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 7.160E-05 | 3.938E-04 | CYP2C9; CYP1A2; CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Adult varicella zoster virus infection | B02 | TK1 |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6 |
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9 |
A00-B99: Certain infectious and parasitic diseases | Infections | A00-B99 | PTPN1 |
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR |
C00-D49: Neoplasms | Thyroid cancer diagnosis | C73 | TSHR |
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | PTGS1 |
C00-D49: Neoplasms | Breast cancer | C50 | CA9 |
C00-D49: Neoplasms | Cancer | C00-C96 | HIF1A; CA9; TK1 |
C00-D49: Neoplasms | Brain cancer | C71, D33 | TK1 |